Insider Transactions in Q2 2022 at Relmada Therapeutics, Inc. (RLMD)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
Sergio Traversa Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,012
-7.91%
|
$304,228
$19.19 P/Share
|
|
Jun 30
2022
|
Sergio Traversa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,012
+13.26%
|
$256,192
$16.0 P/Share
|
|
Apr 04
2022
|
Paul Edward Kelly Director |
SELL
Open market or private sale
|
Direct |
10,000
-5.07%
|
$300,000
$30.04 P/Share
|
|
Apr 04
2022
|
Paul Edward Kelly Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.82%
|
$30,000
$3.24 P/Share
|
|
Apr 01
2022
|
Charles J Casamento Director |
SELL
Open market or private sale
|
Direct |
19,800
-40.83%
|
$574,200
$29.0 P/Share
|
|
Apr 01
2022
|
Charles J Casamento Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,800
+50.0%
|
$59,400
$3.24 P/Share
|